Lilly up 8% on strong earnings gain

But still well below high in July.

1 Like

So is Nvida. I’m still holding on to my LLY shares.

You never know when these big drug companies are going to find a $20 or $100 Billion drug. It’s just like drilling for oil.

And with AI and the new DeepMind protein folding software, the pace of drug development is being accelerated

intercst

5 Likes

That’s my thinking too. Nvidia is a true growth stock. Drug stocks can do well but they can be volatile as rumors circulate on the prospects of the latest drug. Block busters are very valuable but not a sure thing.

1 Like

LLY is up another 5% to 6% today after one of the brokerage houses put it on their “Top Buy” list.

There may not be a person alive who wouldn’t benefit from a prescription for Zepbound. {{ LOL }}

intercst

1 Like